Functional characterization of genetic enzyme variations in human lipoxygenases

Redox Biology

Volumn 1, Issue 1, 2013, Pages 566-577

  Horn, Thomas ^a   Kakularam, Kumar Reddy ^b   Anton, Monika ^a   Richter, Constanze ^c   Reddanna, Pallu ^b   Kuhn, Hartmut ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HYDERABAD   (India)

^c TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Eicosanoids; Gene polymorphism; Leukotrienes; Lipoxygenases; SNP

Indexed keywords

12 LIPOXYGENASE 12R TYPE; 15 LIPOXYGENASE TYPE 2; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; EPIDERMIS TYPE LIPOXYGENASE 3; LIPOXYGENASE; UNCLASSIFIED DRUG; STOP CODON;

ALOX12 GENE; ALOX12B GENE; ALOX15 GENE; ALOX15B GENE; ALOX5 GENE; ALOXE3 GENE; ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME DENATURATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; MOLECULAR EVOLUTION; MUTATION RATE; PROTEIN CONFORMATION; STOP CODON;

CODON, NONSENSE; EVOLUTION, MOLECULAR; GENETIC VARIATION; HUMANS; LIPOXYGENASE; MODELS, MOLECULAR; MUTATION RATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION;

EID: 84893798556     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.11.001     Document Type: Article

References (70)

1. J.Z. Haeggström, C.D. Funk, Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease, Chem. Rev. 111 (2011) 5866-5898.
2. V.B. O'Donnell, Free radicals and lipid signaling in endothelial cells, Antioxid. Redox Signal. 5 (2) (2003) 195-203.
3. V.N. Bochkov, O.V. Oskolkova, K.G. Birukov, A.L. Levonen, C.J. Binder, J. Stöckl, Generation and biological activities of oxidized phospholipids, Antioxid. Redox Signal. 12 (8) (2010) 1009-1059.
4. I. Ivanov, D. Heydeck, K. Hofheinz, J. Roffeis, V.B. O'Donnell, H. Kuhn, M. Walther, Molecular enzymology of lipoxygenases, Arch. Biochem. Biophys. 503 (2010) 161-174.
5. J. Hansen, A. Garreta, M. Benincasa, M.C. Fusté, M. Busquets, A. Manresa, Bacterial lipoxygenases, a new subfamily of enzymes? A phylogenetic approach, Appl. Microbiol. Biotechnol. 97 (2013) 4737-4747.
6. J. Choi, J.K. Chon, S. Kim, W. Shin, Conformational flexibility in mammalian 15S-lipoxygenase: reinterpretation of the crystallographic data, Proteins 70 (2008) 1023-1032.
7. N.C. Gilbert, S.G. Bartlett, M.T. Waight, D.B. Neau, W.E. Boeglin, A.R. Brash, M. E. Newcomer, The structure of human 5-lipoxygenase, Science 331 (2011) 217-219.
8. S. Xu, T.C. Mueser, L.J. Marnett, M.O. Funk, Crystal structure of 12-lipoxygenase catalytic-domain-inhibitor complex identifies a substrate-binding channel for catalysis, Structure 20 (2012) 1490-1497.
9. G. Riccioni, A. Zanasi, N. Vitulano, B. Mancini, N. D'Orazio, Leukotrienes in atherosclerosis: new target insights and future therapy perspectives, Mediators Inflamm. (2009) 737282. (2009).
10. S.P. Khanapure, D.S. Garvey, D.R. Janero, L.G. Letts, Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers, Curr. Top. Med. Chem. 7 (2007) 311-340.
11. M.C. Cathcart, J. Lysaght, G.P. Pidgeon, Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention, Cancer Metastasis Rev. 30 (2011) 363-385.
12. M. Hersberger, Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins, Clin. Chem. Lab. Med. 48 (2010) 1063-1073.
13. S.E. Kleinstein, L. Heath, K.W. Makar, E.M. Poole, B.L. Seufert, M.L. Slattery, L. Xiao, D.J. Duggan, L. Hsu, K. Curtin, L. Koepl, J. Muehling, D. Taverna, B.J. Caan, C.S. Carlson, J.D. Potter, C.M. Ulrich, Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia, Genes. Chromosomes Cancer. 52 (2013) 437-449.
14. N. Habermann, C.M. Ulrich, A. Lundgreen, K.W. Makar, E.M. Poole, B. Caan, R. Kulmacz, J. Whitton, R. Galbraith, J.D. Potter, M.L. Slattery, PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer, Genes Nutr. 8 (2013) 115-126.
15. H. Sun, J. Zhang, J. Wang, T. Sun, H. Xiao, J.S. Zhang, Association between genetic variants of the leukotriene biosynthesis pathway and the risk of stroke: a case-control study in the Chinese Han population, Chin Med J (Engl) 126 (2013) 254-259.
16. I. Sayers, S. Barton, S. Rorke, J. Sawyer, Q. Peng, B. Beghé, S. Ye, T. Keith, J.B. Clough, J.W. Holloway, A.P. Sampson, S.T. Holgate, Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population, Clin. Exp. Allergy. 33 (2003) 1103-1110.
17. J.H. Dwyer, H. Allayee, K.M. Dwyer, J. Fan, H. Wu, R. Mar, A.J. Lusis, M. Mehrabian, Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis, N Engl J Med 350 (2004) 29-37.
18. T. Harsløf, L.B. Husted, M. Nyegaard, M. Carstens, L. Stenkjær, K. Brixen, P. Eiken, J.E. Jensen, A.D. Børglum, L. Mosekilde, L. Rejnmark, B.L. Langdahl, Polymorphisms in the ALOX12 gene and osteoporosis, Osteoporos. Int. 22 (2011) 2249-2259.
19. V.V. Prasad, P. Kolli, D. Moganti, Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer, Exp. Ther. Med. 2 (2011) 317-323.
20. T. Kim, H.J. Kim, J.K. Park, J.W. Kim, J.H. Chung, Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population, Behav. Brain. Funct. 6 (2010) 44.
21. A.M. Aleem, L. Wells, J. Jankun, M. Walther, H. Kühn, J. Reinartz, E. Skrzypczak-Jankun, Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior, Int. J. Mol. Med. 24 (2009) 759-764.
22. T.L. Assimes, J.W. Knowles, J.R. Priest, A. Basu, A. Borchert, K.A. Volcik, M.L. Grove, H.K. Tabor, A. Southwick, R. Tabibiazar, S. Sidney, E. Boerwinkle, A.S. Go, C. Iribarren, M.A. Hlatky, S.P. Fortmann, R.M. Myers, H. Kuhn, N. Risch, T. Quertermous, A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease, Atherosclerosis 198 (2008) 136-14 4.
23. K. Schurmann, M. Anton, I. Ivanov, C. Richter, H. Kuhn, M. Walther, Molecular basis for the reduced catalytic activity of the naturally occurring T560M mutant of human 12/15-lipoxygenase that has been implicated in coronary artery disease, J. Biol. Chem. 286 (2011) 23920-23927.
24. T. Horn, I. Ivanov, A. Di Venere, K.R. Kakularam, P. Reddanna, M.L. Conrad, C. Richter, P. Scheerer, H. Kuhn, Molecular basis for the catalytic inactivity of a naturally occurring near-null variant of human ALOX15, Biochim. Biophys. Acta1831 (12) (2013) 1702-1713.
25. K.M. Eckl, P. Krieg, W. Küster, H. Traupe, F. André, N. Wittstruck, G. Fürstenberger, H.C. Hennies, Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis, Hum. Mutat. 26 (2005) 351-361.
26. C. Bai, E. Matsui, H. Ohnishi, K. Kimata, K. Kasahara, H. Kaneko, Z. Kato, T. Fukao, N. Kondo, A novel polymorphism, E254K, in the 5-lipoxygenase gene associated with bronchial asthma, Int. J. Mol. Med. 21 (2008) 139-14 4.
27. J. Wang, E.M. John, S.A. Ingles, 5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer, Cancer Epidemiol. Biomarkers Prev. 17 (10) (2008) 2748-2754.
28. G.R. Abecasis, A. Auton, L.D. Brooks, M.A. DePristo, R.M. Durbin, R.E. Handsaker, H.M. Kang, G.T. Marth, G.A. McVean, G.P. Consortium, An integrated map of genetic variation from 1092 human genomes, Nature 491 (2012) 56-65.
29. D. Lu, S. Xu, Principal component analysis reveals the 1000 Genomes Project does not sufficiently cover the human genetic diversity in Asia, Front Genet. 4 (2013) 127.
30. M. Walther, J. Roffeis, C. Jansen, M. Anton, I. Ivanov, H. Kuhn, Structural basis for pH-dependent alterations of reaction specificity of vertebrate lipoxygenase isoforms, Biochim. Biophys. Acta. 827-835 (1791) 2009.
31. K. Hofheinz, K.R. Kakularam, S. Adel, M. Anton, A. Polymarasetty, P. Reddanna, H. Kuhn, T. Horn, Conversion of pro-inflammatory murine Alox5 into an antiinflammatory 15S-lipoxygenating enzyme by multiple mutations of sequence determinants, Arch. Biochem. Biophys. 530 (2013) 40-47.
32. N. Arora, V.K. Singh, K. Shah, S. Pandey-Rai, Qualitative and Quantitative analysis of 3D predicted arachidonate 15-lipoxygenase-B (15-LOX-2) from Homo sapiens, Bioinformation 8 (2012) 555-561.
33. N. Fernandez-Fuentes, C.J. Madrid-Aliste, B.K. Rai, J.E. Fajardo, A. Fiser, M4T: a comparative protein structure modeling server, Nucleic Acids Res. 35 (2007) W363-W368.
34. N. Fernandez-Fuentes, B.K. Rai, C.J. Madrid-Aliste, J.E. Fajardo, A. Fiser, Comparative protein structure modeling by combining multiple templates and optimizing sequence-to-structure alignments, Bioinformatics 23 (2007) 2558-2565.
35. D. Bhattacharya, J. Cheng, 3Drefine: consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization, Proteins 81 (2013) 119-131.
36. M.T. Nelson, W. Humphrey, A. Gursoy, A. Dalke, L.V. Kalé, R.D. Skeel, K. Schulten, NAMD: a parallel, object oriented molecular dynamics program, Int. J. High Perform. Comput. Appl. 10 (1996) 251-268.
37. A.D. MacKerell Jr., D. Bashford, M. Bellott, R.L. Dunbrack Jr., J.D. Evanseck, M.J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, et al., All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B 102 (1998) 3586-3616.
38. P. Benkert, M. Künzli, T. Schwede, QMEAN server for protein model quality estimation, Nucleic Acids Res. 37 (2009) W510-W514.
39. E. Sigal, C.S. Craik, E. Highland, D. Grunberger, L.L. Costello, R.A. Dixon, J.A. Nadel, Molecular cloning and primary structure of human 15-lipoxygenase, Biochem. Biophys. Res. Commun. 157 (1988) 457-464.
40. M. Berger, K. Schwarz, H. Thiele, I. Reimann, A. Huth, S. Borngräber, H. Kühn, B.J. Thiele, Simultaneous expression of leukocyte-type 12-lipoxygenase and reticulocyte-type 15-lipoxygenase in rabbits, J. Mol. Biol. 278 (1998) 935-948.
41. C. Jansen, K. Hofheinz, R. Vogel, J. Roffeis, M. Anton, P. Reddanna, H. Kuhn, M. Walther, Stereocontrol of arachidonic acid oxygenation by vertebrate lipoxygenases: newly cloned zebrafish lipoxygenase 1 does not follow the Ala-versus-Gly concept, J. Biol. Chem. 286 (2011) 37804-37812.
42. G. Coffa, A.R. Brash, A single active site residue directs oxygenation stereospecificity in lipoxygenases: stereocontrol is linked to the position of oxygenation, Proc. Natl. Acad. Sci. USA 101 (2004) 15579-15584.
43. H. Kuhn, J. Belkner, R. Wiesner, A.R. Brash, Oxygenation of biological membranes by the pure reticulocyte lipoxygenase, J. Biol. Chem. 265 (1990) 18351-18361.
44. M. Walther, R. Wiesner, H. Kuhn, Investigations into calcium-dependent membrane association of 15-lipoxygenase-1. Mechanistic roles of surfaceexposed hydrophobic amino acids and calcium, J. Biol. Chem. 279 (2004) 3717-3725.
45. Q.F. Gan, M.F. Browner, D.L. Sloane, E. Sigal, Defining the arachidonic acid binding site of human 15-lipoxygenase. Molecular modeling and mutagenesis, J. Biol. Chem. 271 (1996) 25412-25418.
46. L. Toledo, L. Masgrau, J.D. Maréchal, J.M. Lluch, A. González-Lafont, Insights into the mechanism of binding of arachidonic acid to mammalian 15-lipoxygenases, J. Phys. Chem. B 114 (2010) 7037-7046.
47. C.D. Funk, T. Matsumoto, S. Hoshiko, O. Rådmark, B. Samuelsson, Characterization of the human 5-lipoxygenase gene, Adv. Prostaglandin Thromboxane Leukot. Res. 19 (1989) 470-473.
48. O. Rådmark, B. Samuelsson, Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis, Biochem. Biophys. Res. Commun. 396 (2010) 105-110.
49. K. Schwarz, M. Walther, M. Anton, C. Gerth, I. Feussner, H. Kuhn, Structural basis for lipoxygenase specificity. Conversion of the human leukocyte 5-lipoxygenase to a 15-lipoxygenating enzyme species by site-directed mutagenesis, J. Biol. Chem. 276 (2001) 773-779.
50. M. Hamberg, B. Samuelsson, Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets, Proc. Natl. Acad. Sci. USA 71 (1974) 3400-3404.
51. P. Chaitidis, S. Adel, M. Anton, D. Heydeck, H. Kuhn, T. Horn, Lipoxygenase pathways in Homo neanderthalensis: functional comparison with Homo sapiens isoforms, J. Lipid. Res. 54 (2013) 1397-1409.
52. R. Vogel, C. Jansen, J. Roffeis, P. Reddanna, P. Forsell, H.E. Claesson, H. Kuhn, M. Walther, Applicability of the triad concept for the positional specificity of mammalian lipoxygenases, J. Biol. Chem. 285 (2010) 5369-5376.
53. A.R. Brash, W.E. Boeglin, M.S. Chang, Discovery of a second 15S-lipoxygenase in humans, Proc. Natl. Acad. Sci. USA 94 (1997) 6148-6152.
54. M. Jisaka, R.B. Kim, W.E. Boeglin, A.R. Brash, Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2, J. Biol. Chem. 275 (2000) 1287-1293.
55. D. Sun, M. McDonnell, X.S. Chen, M.M. Lakkis, H. Li, S.N. Isaacs, S.H. Elsea, P.I. Patel, C.D. Funk, Human 12(R)-lipoxygenase and the mouse ortholog. Molecular cloning, expression, and gene chromosomal assignment, J. Biol. Chem. 273 (50) (1998) 33540-33547.
56. W.E. Boeglin, R.B. Kim, A.R. Brash, A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression, Proc. Natl. Acad. Sci. USA 95 (1998) 6744-6749.
57. P. Krieg, M. Siebert, A. Kinzig, R. Bettenhausen, F. Marks, G. Fürstenberger, Murine 12(R)- lipoxygenase: functional expression, genomic structure and chromosomal localization, FEBS Lett. 446 (1999) 142-148.
58. N. Epp, G. Fürstenberger, K. Müller, S. de Juanes, M. Leitges, I. Hausser, F. Thieme, G. Liebisch, G. Schmitz, P. Krieg, 12R-lipoxygenase deficiency disrupts epidermal barrier function, J. Cell Biol., 177, 173-182.
59. P. Krieg, F. Marks, G. Fürstenberger, A gene cluster encoding human epidermistype lipoxygenases at chromosome 17p13.1: cloning, physical mapping, and expression, Genomics 73 (2001) 323-330.
60. A. Kinzig, G. Fürstenberger, F. Bürger, S. Vogel, K. Müller-Decker, A. Mincheva, P. Lichter, F. Marks, P. Krieg, Murine epidermal lipoxygenase (Aloxe) encodes a 12-lipoxygenase isoform, FEBS Lett. 402 (1997) 162-166.
61. Z. Yu, C. Schneider, W.E. Boeglin, A.R. Brash, Human and mouse eLOX3 have distinct substrate specificities: implications for their linkage with lipoxygenases in skin, Arch. Biochem. Biophys. 455 (2) (2006) 188-196.
62. Y. Zheng, A.R. Brash, On the role of molecular oxygen in lipoxygenase activation: comparison and contrast of epidermal lipoxygenase-3 with soybean lipoxygenase-1, J. Biol. Chem. 285 (51) (2010) 39876-39887.
63. Y. Zheng, A.R. Brash, Dioxygenase activity of epidermal lipoxygenase-3 unveiled: typical and atypical features of its catalytic activity with natural and synthetic polyunsaturated fatty acids, J. Biol. Chem. 285 (51) (2010) 39866-39875.
64. I.P. Gorlov, O.Y. Gorlova, M.L. Frazier, M.R. Spitz, C.I. Amos, Evolutionary evidence of the effect of rare variants on disease etiology, Clin. Genet. 79 (2011) 199-206.
65. C.N. Serhan, N. Chiang, T.E. Van Dyke, Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators, Nat. Rev. Immunol. 8 (2008) 349-361.
66. I. Ivanov, W. Shang, L. Toledo, L. Masgrau, D.I. Svergun, S. Stehling, H. Gómez, A. Di Venere, G. Mei, J.M. Lluch, E. Skrzypczak-Jankun, A. González-Lafont, H. Kühn, Ligand-induced formation of transient dimers of mammalian 12/15-lipoxygenase: a key to allosteric behavior of this class of enzymes? Proteins 80 (2012) 703-712.
67. A. Kapoor, M. Shandilya, S. Kundu, Structural insight of dopamine β-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms, PLoS One 6 (2011) e26509.
68. C.M. Yates, M.J. Sternberg, The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein-protein interactions, J. Mol. Biol. 425 (21) (2013) 3949-3963.
69. K.S. Pedersen, W.R. Bamlet, A.L. Oberg, M. de Andrade, M.E. Matsumoto, H. Tang, S.N. Thibodeau, G.M. Petersen, L. Wang, Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls, PLoS One 6 (2011) e18223.
70. L. De Conti, M. Baralle, E. Buratti, Exon and intron definition in pre-mRNA splicing, Wiley Interdiscip Rev. RNA 4 (2013) 49-60.